CELA KOBEL: Open Payments
NPI 1699928184 · CENTENNIAL, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,882 in 85 payments from 29 companies in 2025. Trend: 2023 $36 · 2024 $64 · 2025 $1,882
Food & beverage: $1,882
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $310 |
| Lundbeck LLC | 6 | $220 |
| PFIZER INC. | 13 | $148 |
| ARGENX US, INC. | 5 | $144 |
| Neurocrine BioSciences, Inc. | 5 | $119 |
| Alexion Pharmaceuticals, Inc. | 4 | $110 |
| Axsome Therapeutics, Inc. | 3 | $69 |
| Neurelis, Inc. | 2 | $56 |
| Tanabe Pharma America, Inc. | 2 | $53 |
| AstraZeneca Pharmaceuticals LP | 2 | $51 |
Products named: QULIPTA, VYEPTI, VYVGART HYTRULO, INGREZZA, ULTOMIRIS, NURTEC ODT, Symbravo, VALTOCO.
Industry payments across CO — which companies pay providers there.
